Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Caused by Heart Failure With Reduced Ejection Fraction
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to compare the impact of hemodynamic monitoring using pulmonary artery catheter (PAC) on survival and inotropic agent reduction in patients with cardiogenic shock caused by heart failure with reduced ejection fraction (HFrEF). The investigators also intend to compare the difference in long-term survival rates among patients who have recovered from cardiogenic shock due to HFrEF, based on the timing of initiation of beta-blocker treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Adults age 19 and above ( no age limit for elderly )
• Patients with cardiogenic shock requiring intensive care monitoring in ICU
• Patients eligible for oral medication administration
• Patients who have provided research participation consent through a written informed consent form
Locations
Other Locations
Republic of Korea
Asan Medical Center
RECRUITING
Seoul
Contact Information
Primary
Min-Seok Kim, PhD
msk@amc.seoul.kr
82-2-3010-3948
Backup
Ah-Ram Kim, MD
ahram3256@amc.seoul.kr
82-2-3010-0111
Time Frame
Start Date: 2024-01
Estimated Completion Date: 2028-03
Participants
Target number of participants: 160
Treatments
Experimental: Pulmonary artery catheter monitoring group
Within 8 hours of random allocation, a pulmonary artery catheter will be inserted to monitor hemodynamic parameters.
Active_comparator: No pulmonary artery catheter monitoring group
After random allocation, a pulmonary artery catheter will not be inserted during cardiogenic shock management.
Related Therapeutic Areas
Sponsors
Leads: Min-Seok Kim